首页> 外文期刊>PLOS Neglected Tropical Diseases >Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa
【24h】

Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa

机译:开发一种糖缀合物疫苗来预防撒哈拉以南非洲的侵袭性鼠伤寒沙门氏菌感染

获取原文
       

摘要

Invasive infections associated with non-typhoidal Salmonella (NTS) serovars Enteritidis (SE), Typhimurium (STm) and monophasic variant 1,4,[5],12:i:- are a major health problem in infants and young children in sub-Saharan Africa, and currently, there are no approved human NTS vaccines. NTS O-polysaccharides and flagellin proteins are protective antigens in animal models of invasive NTS infection. Conjugates of SE core and O-polysaccharide (COPS) chemically linked to SE flagellin have enhanced the anti-COPS immune response and protected mice against fatal challenge with a Malian SE blood isolate. We report herein the development of a STm glycoconjugate vaccine comprised of STm COPS conjugated to the homologous serovar phase 1 flagellin protein (FliC) with assessment of the role of COPS O-acetyls for functional immunity. Sun-type COPS conjugates linked through the polysaccharide reducing end to FliC were more immunogenic and protective in mice challenged with a Malian STm blood isolate than multipoint lattice conjugates (>95% vaccine efficacy [VE] versus 30–43% VE). Immunization with de-O-acetylated STm-COPS conjugated to CRM197 provided significant but reduced protection against STm challenge compared to mice immunized with native STm-COPS:CRM197 (63–74% VE versus 100% VE). Although OPS O-acetyls were highly immunogenic, post-vaccination sera that contained various O-acetyl epitope-specific antibody profiles displayed similar in vitro bactericidal activity when equivalent titers of anti-COPS IgG were assayed. In-silico molecular modeling further indicated that STm OPS forms a single dominant conformation, irrespective of O-acetylation, in which O-acetyls extend outward and are highly solvent exposed. These preclinical results establish important quality attributes for an STm vaccine that could be co-formulated with an SE-COPS:FliC glycoconjugate as a bivalent NTS vaccine for use in sub-Saharan Africa.
机译:与非伤寒沙门氏菌肠炎沙门氏菌,鼠伤寒沙门氏菌和单相变种1,4,[5],12:i:-相关的侵袭性感染是亚健康的婴幼儿的主要健康问题撒哈拉以南非洲地区,目前还没有批准的人类NTS疫苗。 NTS O多糖和鞭毛蛋白是侵袭性NTS感染动物模型中的保护性抗原。与SE鞭毛蛋白化学连接的SE核心和O多糖(COPS)的共轭物增强了抗COPS免疫反应,并保护了小鼠免受马里SE血液分离物的致命攻击。我们在此报告了STm糖缀合物疫苗的开发,该疫苗包括与同源血清型1期鞭毛蛋白(FliC)缀合的STm COPS,并评估了COPS O-乙酰基对功能性免疫的作用。通过多糖还原末端连接至FliC的Sun型COPS缀合物在受到马里STm血液分离物攻击的小鼠中比多点晶格缀合物更具免疫原性和保护性(> 95%疫苗功效[VE]对30-43%VE)。与天然STm-COPS:CRM197免疫的小鼠相比,与CRM197偶联的脱O-乙酰化STm-COPS的免疫提供了显着但降低的抗STm攻击的保护(63-74%VE对100%VE)。尽管OPS O-乙酰基具有高度的免疫原性,但当测定抗COPS IgG的等效效价时,包含各种O-乙酰基表位特异性抗体谱的疫苗接种后血清显示出相似的体外杀菌活性。硅内分子模型进一步表明,STm OPS形成单个显性构象,而与O-乙酰化无关,其中O-乙酰基向外延伸并高度暴露于溶剂中。这些临床前结果为STm疫苗建立了重要的质量属性,可与SE-COPS:FliC糖缀合物共同配制为二价NTS疫苗,用于撒哈拉以南非洲。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号